Patents by Inventor Steven R. Post

Steven R. Post has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polynucleotide encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function
    Patent number: 7235236
    Abstract: The present invention relates to polynucleotides encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.
    Type: Grant
    Filed: September 14, 2004
    Date of Patent: June 26, 2007
    Assignee: The Regents of the University of California
    Inventors: H. Kirk Hammond, Paul A. Insel, Peipei Ping, Steven R. Post, Meihua Gao
  • Adenovirus encoding human adenylylcyclase (AC) VI
    Patent number: 6752987
    Abstract: The present invention relates to methods and compositions for enhancing cardiac function in mammalian hearts by inserting transgenes that increase beta-adrenergic responsiveness within the myocardium. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.
    Type: Grant
    Filed: December 27, 1999
    Date of Patent: June 22, 2004
    Assignee: The Regents of the University of California
    Inventors: H. Kirk Hammond, Paul A. Insel, Peipei Ping, Steven R. Post, Meihua Gao
  • Gene therapy for congestive heart failure
    Publication number: 20020103147
    Abstract: The present invention relates to methods and compositions for enhancing cardiac function in mammalian hearts by inserting transgenes that increase beta-adrenergic responsiveness within the myocardium. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.
    Type: Application
    Filed: December 26, 2000
    Publication date: August 1, 2002
    Inventors: H. Kirk Hammond, Paul A. Insel, Peipei Ping, Steven R. Post, Meihua Gao
  • Gene therapy for congestive heart failure
    Patent number: 6306830
    Abstract: The present invention relates to methods and compositions for enhancing cardiac function in mammalian hearts by inserting transgenes that increase &bgr;-adrenergic responsiveness within the myocardium. The present invention can thus be used in the treatment of heart disease, especially congestive heart failure.
    Type: Grant
    Filed: January 16, 1998
    Date of Patent: October 23, 2001
    Assignee: The Regents of the University of California
    Inventors: H. Kirk Hammond, Paul A. Insel, Peipei Ping, Steven R. Post, Meihua Gao